首页 > 最新文献

Translational medicine and exercise prescription最新文献

英文 中文
Targeted Exercise Training for Cancer Patients: Moving beyond Generic Exercise Guidelines in Clinical Oncology 癌症患者的目标运动训练:超越临床肿瘤学的一般运动指南
Pub Date : 2021-06-22 DOI: 10.53941/TMEP.V1I1.35
C. Fairman, J. Christensen
Targeted Exercise Training for Cancer Patients: Moving beyond Generic Exercise Guidelines in Clinical OncologyCiaran M Fairman1 and Jesper F Christensen()2,3 1Department of Exercise Science, University of South Carolina, USA2Center for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark3Department of Sports Science and Clinical Biomechanics, Faculty of Health Sciences, University of Southern Denmark, Denmark© The Authors AbstractThe field of exercise oncology has rapidly evolved over the past 30 years. Initial investigations of safety and feasibility have progressed towards efficacy and effectiveness trials with a variety of health-related outcomes in mind. More recently, it has been recognized that interventions aimed at modifying physical activity behavior (i.e. behavioral interventions to increase participation in un/structured physical activity) are distinctly different from those aiming to target a clinically relevant outcome (using a specific exercise prescription). There is a strong rationale for the latter, where cancer/treatment toxicities can result in musculoskeletal, cardiopulmonary, and/or hematological declines with important prognostic implications. Treatment intolerance, unfavorable tumor response and heightened risk of mortality are all consequences of leaving these impairments unaddressed. Importantly, the control/reversal of the decline in these systems is more likely to occur through a targeted exercise prescription, specifically designed to target the impairment, rather than interventions trying to change behavior. This requires careful consideration in the study design in exercise oncology in relation to the selection of clinically relevant outcomes, decisions on methods of assessments and ensuring the exercise is targeted to the outcome.    The objective of this review is to 1) conceptualize and provide a clinical rationale for targeted exercise interventions in exercise oncology, and 2) provide a framework for consideration in the design and execution in targeted exercise interventions in oncology. We hope that this framework can encourage research into targeted exercise interventions in oncology and that our framework can be used to inform the design of future trials.
针对癌症患者的运动训练:超越临床肿瘤学的一般运动指南ciaran M Fairman1和Jesper F Christensen()2,31南卡罗来纳大学运动科学系2丹麦哥本哈根Rigshospitalet体育活动研究中心3丹麦南丹麦大学健康科学学院运动科学与临床生物力学系©作者摘要运动肿瘤学领域在过去30年中迅速发展。安全性和可行性的初步调查已进展到疗效和有效性试验,考虑到各种与健康相关的结果。最近,人们认识到旨在改变身体活动行为的干预措施(即增加非结构化身体活动参与的行为干预措施)与旨在达到临床相关结果的干预措施(使用特定的运动处方)明显不同。后者有很强的理论基础,其中癌症/治疗毒性可导致肌肉骨骼,心肺和/或血液学下降,具有重要的预后意义。治疗不耐受、不良肿瘤反应和死亡风险增加都是这些损伤未得到解决的后果。重要的是,这些系统衰退的控制/逆转更有可能通过有针对性的运动处方发生,专门针对损伤,而不是试图改变行为的干预。这需要在运动肿瘤学的研究设计中仔细考虑与临床相关结果的选择、评估方法的决定以及确保运动针对结果。本综述的目的是1)概念化并为运动肿瘤学中的靶向运动干预提供临床依据;2)为肿瘤学中靶向运动干预的设计和实施提供一个考虑框架。我们希望这个框架可以鼓励对肿瘤中有针对性的运动干预的研究,我们的框架可以用来指导未来试验的设计。
{"title":"Targeted Exercise Training for Cancer Patients: Moving beyond Generic Exercise Guidelines in Clinical Oncology","authors":"C. Fairman, J. Christensen","doi":"10.53941/TMEP.V1I1.35","DOIUrl":"https://doi.org/10.53941/TMEP.V1I1.35","url":null,"abstract":"Targeted Exercise Training for Cancer Patients: Moving beyond Generic Exercise Guidelines in Clinical Oncology\u0000\u0000Ciaran M Fairman1 and Jesper F Christensen()2,3 \u0000\u0000\u00001Department of Exercise Science, University of South Carolina, USA\u00002Center for Physical Activity Research, Rigshospitalet, Copenhagen, Denmark\u00003Department of Sports Science and Clinical Biomechanics, Faculty of Health Sciences, University of Southern Denmark, Denmark\u0000\u0000© The Authors\u0000\u0000 \u0000Abstract\u0000The field of exercise oncology has rapidly evolved over the past 30 years. Initial investigations of safety and feasibility have progressed towards efficacy and effectiveness trials with a variety of health-related outcomes in mind. More recently, it has been recognized that interventions aimed at modifying physical activity behavior (i.e. behavioral interventions to increase participation in un/structured physical activity) are distinctly different from those aiming to target a clinically relevant outcome (using a specific exercise prescription). There is a strong rationale for the latter, where cancer/treatment toxicities can result in musculoskeletal, cardiopulmonary, and/or hematological declines with important prognostic implications. Treatment intolerance, unfavorable tumor response and heightened risk of mortality are all consequences of leaving these impairments unaddressed. Importantly, the control/reversal of the decline in these systems is more likely to occur through a targeted exercise prescription, specifically designed to target the impairment, rather than interventions trying to change behavior. This requires careful consideration in the study design in exercise oncology in relation to the selection of clinically relevant outcomes, decisions on methods of assessments and ensuring the exercise is targeted to the outcome.\u0000    The objective of this review is to 1) conceptualize and provide a clinical rationale for targeted exercise interventions in exercise oncology, and 2) provide a framework for consideration in the design and execution in targeted exercise interventions in oncology. We hope that this framework can encourage research into targeted exercise interventions in oncology and that our framework can be used to inform the design of future trials.","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73889428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical Activity and Fatigue in Multiple Sclerosis: Secondary Outcomes from a Double-blinded Randomized Controlled Trial of Cocoa Flavonoid Drinks 多发性硬化症的体力活动和疲劳:可可类黄酮饮料双盲随机对照试验的次要结果
Pub Date : 2021-06-22 DOI: 10.53941/tmep.v1i1.36
Maedeh Mansoubi, S. Coe, J. Cossington, J. Collet, M. Clegg, J. Palace, A. Cavey, G. DeLuca, Martin Ovington, H. Dawes
Physical Activity and Fatigue in Multiple Sclerosis: Secondary Outcomes from a Double-blinded Randomized Controlled Trial of Cocoa Flavonoid DrinksMaedeh Mansoubi()1,2, Shelly Coe1,2,3, Jo Cossington1, Johnny Collet1,2, Miriam Clegg4, Jacqueline Palace5, Ana Cavey5, Gabriele C DeLuca5, Martin Ovington1 and Helen Dawes1,2,6 1Center for Movement, Occupational and Rehabilitation Sciences, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford Brookes University, Oxford, United Kingdom2Oxford Clinical Allied Technology and Trial Services Unit (OxCATTS), Oxford, United Kingdom3Oxford Brookes Center for Nutrition and Health, Oxford Brookes University, Oxford, United Kingdom4Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Reading, United Kingdom5Department of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom6Oxford Health NHS Foundation Trust, United Kingdom© The Authors AbstractFatigue is a common and pervasive symptom reducing physical activity in people with multiple sclerosis (pwMS). Exercise may reduce fatigue, although evidence to guide optimal prescription is limited. Specifically, supportive evidence for the timing of exercise for fatigue management or the impact of dietary supplements is unavailable. We performed intensive phenotyping of the interrelation of time of day, physical activity levels, and fatigue to evidence exercise prescription in 40 pwMS participating in a six week randomized controlled trial of morning flavonoid intake (n=19) or a control (n=21). Physical activity was measured over seven days by using an accelerometer at baseline, week three and week six. Participants self-reported their fatigue on a 1–10 rating scale at 10 am, 3 pm, and 8 pm daily. Physical activity levels were calculated for 2.5 h before and after fatigue was reported. Generalized estimating equations were used to explore the time of day fatigue profiles, the relationship of physical activity to fatigue, and the effect of morning flavonoids on this relationship. Participants experienced higher fatigue at 8 pm (4.64±2.29) than at 3 pm (4.39±2.28) and 10 am (3.90±2.10) (P<0.001). Higher fatigue was shown to predict subsequent lower physical activity behavior (P=0.015), but physical activity did not predict higher subsequent fatigue (P>0.05). Morning flavonoid cocoa consumption reduced the relationship of fatigue to physical activity (P=0.049) and fatigue to time of the day (P<0.001). Fatigue levels increased during the day and higher fatigue reduced physical activity in pwMS, but physical activity did not increase fatigue. In addition, morning cocoa reduced daytime fatigue and the relationship of fatigue to subsequent physical activity levels. Therefore morning exercise prescription is indicated; in combination with dietary flavonoids, it may optimize exercise and physical activity potential in pwMS.Trial registrati
多发性硬化症患者的体力活动与疲劳可可类黄酮饮料双盲随机对照试验的辅助结果madeh Mansoubi()1,2,Shelly Coe1,2,3, Jo Cossington1, Johnny Collet1,2, Miriam Clegg4, Jacqueline Palace5, Ana Cavey5, Gabriele C DeLuca5, Martin Ovington1和Helen dawes 1,2,6 1牛津布鲁克斯大学牛津护理、助产和联合健康研究研究所运动、职业和康复科学中心,牛津,英国2英国牛津牛津临床联合技术和试验服务处(OxCATTS) 3英国牛津牛津牛津布鲁克斯大学牛津布鲁克斯营养与健康中心4英国雷丁大学雷丁食品与营养科学系休·辛克莱人类营养处5英国牛津牛津大学纳菲尔德临床神经科学系神经内科6牛津健康NHS基金会信托基金英国©作者摘要疲劳是多发性硬化症(pwMS)患者减少体力活动的常见且普遍的症状。运动可以减轻疲劳,尽管指导最佳处方的证据有限。具体来说,目前还没有支持运动时间对疲劳管理或膳食补充剂影响的证据。我们对40名参加为期六周的早晨类黄酮摄入随机对照试验(n=19)或对照组(n=21)的pwMS进行了密集的表型分析,以证明运动处方与一天中的时间、身体活动水平和疲劳之间的相互关系。在基线、第3周和第6周使用加速度计测量7天内的身体活动。参与者在每天上午10点、下午3点和晚上8点以1-10的等级自报疲劳程度。计算疲劳报告前后2.5 h的体力活动水平。采用广义估计方程探讨了一天中疲劳的时间分布、体力活动与疲劳的关系,以及早晨黄酮类化合物对这种关系的影响。参与者在晚上8点(4.64±2.29)比下午3点(4.39±2.28)和上午10点(3.90±2.10)的疲劳程度更高(P0.05)。早晨摄入类黄酮可可降低了疲劳与体力活动的关系(P=0.049)和疲劳与一天中的时间的关系(P<0.001)。白天疲劳水平增加,高疲劳减少了pwMS的体力活动,但体力活动没有增加疲劳。此外,早上喝可可还能减少白天的疲劳,以及疲劳与随后的身体活动水平之间的关系。因此建议开晨练处方;与膳食黄酮类化合物联合使用,可优化pwMS患者的运动和体力活动潜力。试验注册:ISRCTN69897291, https://doi.org/10.1186/ISRCTN69897291Registration名称:一项研究,旨在确定每天食用富含类黄酮的纯可可是否有可能减轻复发-缓解型多发性硬化症(RRMS)患者的疲劳。Consort声明:在本研究中,我们遵循Consort指南。由于本文是二次分析,因此我们没有重复Coe et al. 2019撰写的第一篇论文中已发表的方法、结果、图表或表格中的某些部分。
{"title":"Physical Activity and Fatigue in Multiple Sclerosis: Secondary Outcomes from a Double-blinded Randomized Controlled Trial of Cocoa Flavonoid Drinks","authors":"Maedeh Mansoubi, S. Coe, J. Cossington, J. Collet, M. Clegg, J. Palace, A. Cavey, G. DeLuca, Martin Ovington, H. Dawes","doi":"10.53941/tmep.v1i1.36","DOIUrl":"https://doi.org/10.53941/tmep.v1i1.36","url":null,"abstract":"Physical Activity and Fatigue in Multiple Sclerosis: Secondary Outcomes from a Double-blinded Randomized Controlled Trial of Cocoa Flavonoid Drinks\u0000\u0000Maedeh Mansoubi()1,2, Shelly Coe1,2,3, Jo Cossington1, Johnny Collet1,2, Miriam Clegg4, Jacqueline Palace5, Ana Cavey5, Gabriele C DeLuca5, Martin Ovington1 and Helen Dawes1,2,6 \u0000\u0000\u00001Center for Movement, Occupational and Rehabilitation Sciences, Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford Brookes University, Oxford, United Kingdom\u00002Oxford Clinical Allied Technology and Trial Services Unit (OxCATTS), Oxford, United Kingdom\u00003Oxford Brookes Center for Nutrition and Health, Oxford Brookes University, Oxford, United Kingdom\u00004Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading, Reading, United Kingdom\u00005Department of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom\u00006Oxford Health NHS Foundation Trust, United Kingdom\u0000\u0000© The Authors\u0000\u0000 \u0000Abstract\u0000Fatigue is a common and pervasive symptom reducing physical activity in people with multiple sclerosis (pwMS). Exercise may reduce fatigue, although evidence to guide optimal prescription is limited. Specifically, supportive evidence for the timing of exercise for fatigue management or the impact of dietary supplements is unavailable. We performed intensive phenotyping of the interrelation of time of day, physical activity levels, and fatigue to evidence exercise prescription in 40 pwMS participating in a six week randomized controlled trial of morning flavonoid intake (n=19) or a control (n=21). Physical activity was measured over seven days by using an accelerometer at baseline, week three and week six. Participants self-reported their fatigue on a 1–10 rating scale at 10 am, 3 pm, and 8 pm daily. Physical activity levels were calculated for 2.5 h before and after fatigue was reported. Generalized estimating equations were used to explore the time of day fatigue profiles, the relationship of physical activity to fatigue, and the effect of morning flavonoids on this relationship. Participants experienced higher fatigue at 8 pm (4.64±2.29) than at 3 pm (4.39±2.28) and 10 am (3.90±2.10) (P<0.001). Higher fatigue was shown to predict subsequent lower physical activity behavior (P=0.015), but physical activity did not predict higher subsequent fatigue (P>0.05). Morning flavonoid cocoa consumption reduced the relationship of fatigue to physical activity (P=0.049) and fatigue to time of the day (P<0.001). Fatigue levels increased during the day and higher fatigue reduced physical activity in pwMS, but physical activity did not increase fatigue. In addition, morning cocoa reduced daytime fatigue and the relationship of fatigue to subsequent physical activity levels. Therefore morning exercise prescription is indicated; in combination with dietary flavonoids, it may optimize exercise and physical activity potential in pwMS.\u0000Trial registrati","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86839750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Resistance Training for Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis 抗阻训练对特发性肺纤维化患者康复的影响
Pub Date : 2021-06-16 DOI: 10.53941/TMEP.V1I1.34
B. Vainshelboim, J. Myers
Resistance Training for Rehabilitation in Patients with Idiopathic Pulmonary FibrosisBaruch Vainshelboim()1 and Jonathan Myers2 1Cardiovascular and Metabolic Disease Research Institute, Mountain View, CA, USA2Cardiology Division, Veterans Affairs Palo Alto Health Care System / Stanford University, Palo Alto, CA, USA© The Authors AbstractIdiopathic pulmonary fibrosis (IPF) is a debilitating condition that causes severe symptoms, impaired functional capacity and poor quality of life. Exercise training has been shown to be a safe and effective therapy for improving physical function, dyspnea and quality of life in patients with IPF. However, due to pathophysiological limitations and symptom burden, conducting safe and effective exercise interventions is challenging; optimal program components and training modalities are yet to be established. Resistance training (RT) is a well-established exercise modality for combating effects of aging, disuse and chronic diseases, although there are scarce data available among patients with IPF. The current review briefly summarizes the pathophysiology and clinical manifestations of IPF and describes the numerous health and clinical benefits of RT among older adults and patients with respiratory disease. It then explores the potential RT mechanisms for overcoming exercise limitations in IPF, which may provide a therapeutic opportunity for rehabilitation. Finally, the review suggests practical RT recommendations for pulmonary rehabilitation programs in patients with IPF.
特发性肺纤维化患者的康复阻力训练baruch Vainshelboim()1和Jonathan Myers2 1心血管和代谢疾病研究所,Mountain View, CA, USA; 2退伍军人事务帕洛阿尔托医疗保健系统心脏病学部门/斯坦福大学帕洛阿尔托,CA, USA©作者摘要特发性肺纤维化(IPF)是一种使人衰弱的疾病,会导致严重的症状、功能能力受损和生活质量差。运动训练已被证明是一种安全有效的治疗方法,可以改善IPF患者的身体功能、呼吸困难和生活质量。然而,由于病理生理限制和症状负担,进行安全有效的运动干预是具有挑战性的;最佳方案组成部分和培训方式尚未确定。阻力训练(RT)是一种成熟的运动方式,用于对抗衰老,废用和慢性疾病的影响,尽管在IPF患者中缺乏可用的数据。本文简要总结了IPF的病理生理学和临床表现,并描述了RT在老年人和呼吸系统疾病患者中的众多健康和临床益处。然后探讨了克服IPF运动限制的潜在RT机制,这可能为康复提供治疗机会。最后,本综述对IPF患者的肺康复方案提出了实用的RT建议。
{"title":"Resistance Training for Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis","authors":"B. Vainshelboim, J. Myers","doi":"10.53941/TMEP.V1I1.34","DOIUrl":"https://doi.org/10.53941/TMEP.V1I1.34","url":null,"abstract":"Resistance Training for Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis\u0000\u0000Baruch Vainshelboim()1 and Jonathan Myers2 \u0000\u0000\u00001Cardiovascular and Metabolic Disease Research Institute, Mountain View, CA, USA\u00002Cardiology Division, Veterans Affairs Palo Alto Health Care System / Stanford University, Palo Alto, CA, USA\u0000\u0000© The Authors\u0000\u0000 \u0000Abstract\u0000Idiopathic pulmonary fibrosis (IPF) is a debilitating condition that causes severe symptoms, impaired functional capacity and poor quality of life. Exercise training has been shown to be a safe and effective therapy for improving physical function, dyspnea and quality of life in patients with IPF. However, due to pathophysiological limitations and symptom burden, conducting safe and effective exercise interventions is challenging; optimal program components and training modalities are yet to be established. Resistance training (RT) is a well-established exercise modality for combating effects of aging, disuse and chronic diseases, although there are scarce data available among patients with IPF. The current review briefly summarizes the pathophysiology and clinical manifestations of IPF and describes the numerous health and clinical benefits of RT among older adults and patients with respiratory disease. It then explores the potential RT mechanisms for overcoming exercise limitations in IPF, which may provide a therapeutic opportunity for rehabilitation. Finally, the review suggests practical RT recommendations for pulmonary rehabilitation programs in patients with IPF.","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76891167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise, Pharmaceutical Therapies and Type 2 Diabetes: Looking beyond Glycemic Control to Whole Body Health and Function 运动,药物治疗和2型糖尿病:超越血糖控制到全身健康和功能
Pub Date : 2021-06-16 DOI: 10.53941/TMEP.V1I1.33
T. Yates, J. Henson, J. Sargeant, J. King, E. Ahmad, F. Zaccardi, M. Davies
Exercise, Pharmaceutical Therapies and Type 2 Diabetes: Looking beyond Glycemic Control to Whole Body Health and FunctionThomas Yates()1,2, Joseph Henson1,2, Jack Sargeant1,2, James A King2,4, Ehtasham Ahmad1, Francesco Zaccardi1,3 and Melanie J Davies1,2 1Diabetes Research Center, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK2NIHR Leicester Biomedical Research Center, University Hospitals of Leicester NHS Trust and University of Leicester, UK3Leicester Real World Evidence Unit, Diabetes Research Center, University of Leicester, Leicester, UK4National Center for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, UK© The Authors AbstractExercise is a powerful therapy for improving glycemic control and increasing cardiorespiratory fitness in adults with type 2 diabetes mellitus (T2DM). However, there is a dearth of evidence investigating interactions or synergies between exercise and most pharmaceutical therapies. This is important as exercise is rarely prescribed in isolation of other background medications used to manage T2DM. Therefore understanding which exercise and drug combinations optimize or blunt responses is crucial. This narrative review discusses advances in weight loss management in diabetes and highlights research opportunities and challenges for combining exercise therapies with newer generations of glucose-lowering therapies with weight loss effects, particularly glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is). We discuss the role of exercise in preserving lean mass and increasing physical function along with other potential areas of synergy. We conclude that until the evidence base investigating areas of interaction or synergy between exercise and other glucose-lowering or weight loss therapies is developed, exercise will remain a generic rather than a tailored therapy in the management of T2DM. 
运动、药物治疗和2型糖尿病:从血糖控制到全身健康和功能thomas Yates()1,2,Joseph henson1,2, Jack sargeant1,2, James A king 2,4, Ehtasham Ahmad1, Francesco Zaccardi1,3和Melanie J davis 1,2莱斯特大学糖尿病研究中心,莱斯特大学,莱斯特综合医院,莱斯特,LE5 4PW, UK2NIHR莱斯特生物医学研究中心,莱斯特大学医院NHS信托和莱斯特大学,uk3莱斯特真实世界证据单位,糖尿病研究中心,莱斯特大学,英国莱斯特4拉夫堡大学体育、运动与健康科学学院国家运动与运动医学中心©作者摘要:运动是改善2型糖尿病(T2DM)成人血糖控制和增强心肺健康的有效疗法。然而,缺乏证据调查运动和大多数药物治疗之间的相互作用或协同作用。这一点很重要,因为运动很少与其他治疗2型糖尿病的背景药物分开开。因此,了解哪种运动和药物组合可以优化或减弱反应是至关重要的。本文讨论了糖尿病减肥管理的进展,并强调了将运动疗法与具有减肥效果的新一代降糖疗法相结合的研究机遇和挑战,特别是胰高血糖素样肽-1受体激动剂(GLP-1RAs)和钠-葡萄糖共转运蛋白2抑制剂(SGLT2is)。我们讨论了运动在保持瘦质量和增加身体机能方面的作用以及其他潜在的协同作用。我们的结论是,在研究运动与其他降糖或减肥疗法之间的相互作用或协同作用的证据基础被开发出来之前,运动在2型糖尿病的治疗中仍将是一种通用的治疗方法,而不是量身定制的治疗方法。
{"title":"Exercise, Pharmaceutical Therapies and Type 2 Diabetes: Looking beyond Glycemic Control to Whole Body Health and Function","authors":"T. Yates, J. Henson, J. Sargeant, J. King, E. Ahmad, F. Zaccardi, M. Davies","doi":"10.53941/TMEP.V1I1.33","DOIUrl":"https://doi.org/10.53941/TMEP.V1I1.33","url":null,"abstract":"Exercise, Pharmaceutical Therapies and Type 2 Diabetes: Looking beyond Glycemic Control to Whole Body Health and Function\u0000\u0000Thomas Yates()1,2, Joseph Henson1,2, Jack Sargeant1,2, James A King2,4, Ehtasham Ahmad1, Francesco Zaccardi1,3 and Melanie J Davies1,2 \u0000\u0000\u00001Diabetes Research Center, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW, UK\u00002NIHR Leicester Biomedical Research Center, University Hospitals of Leicester NHS Trust and University of Leicester, UK\u00003Leicester Real World Evidence Unit, Diabetes Research Center, University of Leicester, Leicester, UK\u00004National Center for Sport and Exercise Medicine, School of Sport, Exercise and Health Sciences, Loughborough University, UK\u0000\u0000© The Authors\u0000\u0000 \u0000Abstract\u0000Exercise is a powerful therapy for improving glycemic control and increasing cardiorespiratory fitness in adults with type 2 diabetes mellitus (T2DM). However, there is a dearth of evidence investigating interactions or synergies between exercise and most pharmaceutical therapies. This is important as exercise is rarely prescribed in isolation of other background medications used to manage T2DM. Therefore understanding which exercise and drug combinations optimize or blunt responses is crucial. This narrative review discusses advances in weight loss management in diabetes and highlights research opportunities and challenges for combining exercise therapies with newer generations of glucose-lowering therapies with weight loss effects, particularly glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is). We discuss the role of exercise in preserving lean mass and increasing physical function along with other potential areas of synergy. We conclude that until the evidence base investigating areas of interaction or synergy between exercise and other glucose-lowering or weight loss therapies is developed, exercise will remain a generic rather than a tailored therapy in the management of T2DM. ","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87137022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Translational Medicine and Exercise Prescription (TMEP): Advancing the Era of Exercise Medicine 转化医学和运动处方(TMEP):推进运动医学时代
Pub Date : 2021-06-07 DOI: 10.53941/tmep.v1i1.27
Sulin Cheng, M. Schumann, W. Bloch
Translational Medicine and Exercise Prescription (TMEP): Advancing the Era of Exercise MedicineSulin Cheng1,2,3,4, Moritz Schumann()2,4 and Wilhelm Bloch41Exercise, Health and Technology Center, Department of Physical Education, Shanghai Jiao Tong University, Shanghai, China2Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China3Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland4Department of Molecular and Cellular Sport Medicine, German Sport University, Cologne, Germany© The Authors"Exercise is medicine" has gained popularity worldwide after the American Medical Association and the American College of Sports Medicine co-launched their ground-breaking health initiative in 20071 . This initiative was aimed at improving population health and well-being, mainly by raising the awareness of healthcare providers to regard performing physical activity (PA) as one of the vital signs. Ever since, this concept has spread worldwide and PA has been proposed as an essential part of treatment for chronic diseases2 . In their pioneering work, Pedersen and Saltin provided compelling evidence for the role of exercise as the first- or second-line therapy for at least 26 diseases2 . These findings are further corroborated by meta-epidemiological data, indicating exercise interventions to be as effective as drug interventions, such as during rehabilitation after stroke and for the treatment of heart failure3 . However, the overall effect appears to be strongly correlated with important determinants of the exercise program performed (i.e. dose of training [frequency, volume, intensity], type of exercise and adherence to the training program) and disease-related specifics4 , thus requiring not only clinical expertise but also an in-depth understanding of exercise physiology and biology.  In this new journal-Translational Medicine and Exercise Prescription (TMEP), we are aiming to bring together the fields of exercise physiology and biology, sports medicine and the science of physical training and testing to bridge the gap between mechanistic research and clinical practice. The journal covers nine sections, including obesity, diabetes, cancer, cardiovascular diseases, neurological and psychiatric diseases, pulmonary diseases, musculoskeletal diseases, endocrine disorders as well as advanced exercise prescription and health maintenance. In this first issue of TMEP, we are delighted to present seven papers from different areas of translational research performed in humans on specific themes related to the treatment and prevention of chronic diseases.  Appropriate selection of primary and secondary endpoints is critical for successfully designing translational studies. In the first paper of this issue, TMEP Section Editor, Jörn Rittweger provides his thoughts on "What Are Good Muscle Endpoints for Translational Studies?". In his important work, he highli
肥胖和不健康的生活方式也是2型糖尿病(T2DM)的危险因素。TMEP部分编辑Thomas Yates的研究小组通过题为“运动、药物治疗和2型糖尿病:从血糖控制到全身健康和功能”的叙述综述,强调了运动和医学治疗相结合的研究机遇和挑战。作者提供了新一代降糖疗法的证据,这些疗法也能诱导伴随的体重减轻,特别是胰高血糖素样肽-1受体激动剂(GLP-1RAs)和钠-葡萄糖共转运蛋白2抑制剂(SGLT2is)。基于目前的知识,他们强调了研究运动与其他降糖或减肥疗法之间的相互作用或协同作用的重要性,使运动成为治疗2型糖尿病的量身定制的治疗方法,而不是通用的治疗方法。因此,这篇综述清楚地强调了精确运动处方的必要性,这源于对运动效果的深入机制理解。癌症是另一种重要的代谢和慢性炎症性疾病,也可能与肥胖有关。TMEP部分编辑Jesper F Christensen和副编辑Ciaran M Fairman在他们的文章《针对癌症患者的运动训练:超越临床肿瘤学的一般运动指南》中提供了一个非常有趣的观点。本文旨在更新运动肿瘤学中有针对性的运动干预的现有知识和临床依据。此外,本文还提出了一个系统指导肿瘤学中有针对性的运动干预的设计和执行的框架。作者希望他们的框架可以鼓励对肿瘤中有针对性的运动干预的进一步研究,也可以作为未来试验设计的指导方针,以提高质量和影响。TMEP章节编辑Helen Dawes小组在题为“多发性硬化症中的体力活动和疲劳:可可类黄酮饮料双盲随机对照试验的次要结果”的文章中分享了他们在神经和精神疾病背景下的原始数据。在这项研究中,他们对一天中的时间、身体活动水平和疲劳之间的相互关系进行了密集的表型分析,以确定一组多发性硬化症(MS)患者的运动处方,这些患者参加了一项为期六周的早晨类黄酮摄入量随机对照试验。研究发现,白天的疲劳程度会增加,而疲劳程度越高,体力活动就越少;然而,体育活动本身并不会增加疲劳。此外,早上摄入可可可以减少白天的疲劳和随后的体力活动引起的疲劳。因此,晨操和膳食黄酮类化合物的联合处方可能会优化ms患者的运动和身体活动潜力。这项研究很好地说明了理解和考虑营养和时间生物学等可能的协变量对于确定最佳运动处方模型的重要性。TMEP部分编辑Jonathan Myers和同事Baruch Vainshelboim对“特发性肺纤维化患者康复的阻力训练”进行了叙述性回顾。本文综述了特发性肺纤维化(IPF)的病理生理学和临床表现,重点介绍了老年人和患有这种呼吸系统疾病的患者进行抗阻训练的众多健康和临床益处。本文有效地探讨了系统阻力训练可能有助于克服IPF运动限制的潜在机制,为康复提供治疗机会。此外,作者还为IPF患者提供了基于阻力训练的肺康复方案的重要建议。在这篇论文中,作者强调,适应疾病的运动处方需要病理生理学的理解来证明特定运动方案的合理性。在本期特刊的最后一篇论文中,章节编辑Anthony C Hackney的研究小组分享了他们关于“竞技、非精英男性耐力运动员的能量可用性和RED-S风险因素”的原始数据。本文特别强调了TMEP的整个范围,即不仅仅是最常见的非传染性疾病类型,还包括可能由运动训练引起的慢性病。在这项研究中,作者评估了60名竞技性、娱乐性训练的男性耐力运动员的能量可用性和运动中相对能量缺乏(RED-S)的风险因素之间的关系。他们发现,即使在能量可用性较低的情况下,激素和骨骼生物标志物也在正常的临床范围内。
{"title":"Translational Medicine and Exercise Prescription (TMEP): Advancing the Era of Exercise Medicine","authors":"Sulin Cheng, M. Schumann, W. Bloch","doi":"10.53941/tmep.v1i1.27","DOIUrl":"https://doi.org/10.53941/tmep.v1i1.27","url":null,"abstract":"Translational Medicine and Exercise Prescription (TMEP): Advancing the Era of Exercise Medicine\u0000\u0000Sulin Cheng1,2,3,4, Moritz Schumann()2,4 and Wilhelm Bloch4\u0000\u0000\u00001Exercise, Health and Technology Center, Department of Physical Education, Shanghai Jiao Tong University, Shanghai, China\u00002Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China\u00003Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland\u00004Department of Molecular and Cellular Sport Medicine, German Sport University, Cologne, Germany\u0000\u0000© The Authors\u0000\u0000\"Exercise is medicine\" has gained popularity worldwide after the American Medical Association and the American College of Sports Medicine co-launched their ground-breaking health initiative in 20071 . This initiative was aimed at improving population health and well-being, mainly by raising the awareness of healthcare providers to regard performing physical activity (PA) as one of the vital signs. Ever since, this concept has spread worldwide and PA has been proposed as an essential part of treatment for chronic diseases2 . In their pioneering work, Pedersen and Saltin provided compelling evidence for the role of exercise as the first- or second-line therapy for at least 26 diseases2 . These findings are further corroborated by meta-epidemiological data, indicating exercise interventions to be as effective as drug interventions, such as during rehabilitation after stroke and for the treatment of heart failure3 . However, the overall effect appears to be strongly correlated with important determinants of the exercise program performed (i.e. dose of training [frequency, volume, intensity], type of exercise and adherence to the training program) and disease-related specifics4 , thus requiring not only clinical expertise but also an in-depth understanding of exercise physiology and biology.\u0000  In this new journal-Translational Medicine and Exercise Prescription (TMEP), we are aiming to bring together the fields of exercise physiology and biology, sports medicine and the science of physical training and testing to bridge the gap between mechanistic research and clinical practice. The journal covers nine sections, including obesity, diabetes, cancer, cardiovascular diseases, neurological and psychiatric diseases, pulmonary diseases, musculoskeletal diseases, endocrine disorders as well as advanced exercise prescription and health maintenance. In this first issue of TMEP, we are delighted to present seven papers from different areas of translational research performed in humans on specific themes related to the treatment and prevention of chronic diseases.\u0000  Appropriate selection of primary and secondary endpoints is critical for successfully designing translational studies. In the first paper of this issue, TMEP Section Editor, Jörn Rittweger provides his thoughts on \"What Are Good Muscle Endpoints for Translational Studies?\". In his important work, he highli","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88258954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Energy Availability and RED-S Risk Factors in Competitive, Non-elite Male Endurance Athletes. 竞技非精英男性耐力运动员能量可得性与RED-S危险因素
Pub Date : 2021-06-07 DOI: 10.53941/tmep.v1i1.29
Amy R. Lane, A. Hackney, A. Smith‐Ryan, Kristen L. Kucera, J. Register-Mihalik, K. Ondrak
Relative Energy Deficiency in Sport (RED-S) is predicated on the assumption that low energy availability (EA) induces deficiencies-dysfunction in multiple physiologic systems. However, research on RED-S and EA in male athletes is limited in comparison to women. The aim of this study is to investigate EA and the risk factors for RED-S, and their potential associations in non-elite male endurance athletes. Laboratory assessments for resting metabolic rate (RMR), bone mineral density (BMD), blood hormonal biomarkers and maximal aerobic capacity were conducted on 60 competitive, recreationally trained male endurance athletes (age=43.4±11.6 years [mean±SD], training=10.9±2.7 h/wk, 7.1±8.8 years). Participants provided 7-days of training logs and 4-days of diet records. Diet and training records were used to calculate EA. Correlations were used to examine associations between EA and RMR, BMD, stress fractures and reproductive, metabolic and bone biomarkers. Mean EA was 28.7±13.4 kcal/kg fat free mass (FFM), which categorized our sample as low EA (based upon published criterion, < 30 kcal/kg FFM) and at a high risk for RED-S. Hormonal and bone biomarkers were in normal clinical ranges, even though EA was low. The only interesting significant association was EA being negatively associated with total body BMD (r = -0.360, P =0.005), opposite of expectations. On average our subjects displayed a state of low EA based upon the criterion which has been primarily developed from female-based research. Nonetheless, our participants displayed no major hormonal or bone health disturbances found in athletes diagnosed with RED-S. A value of < 30 kcal/kg FFM to diagnose low EA may not be appropriate for non-elite endurance trained men.
运动中的相对能量不足(RED-S)是基于低能量可用性(EA)导致多个生理系统的缺陷和功能障碍的假设。然而,与女性相比,男性运动员的RED-S和EA研究有限。本研究旨在探讨非优秀男性耐力运动员EA、RED-S危险因素及其潜在关联。对60名竞技性、娱乐性训练的男性耐力运动员(年龄=43.4±11.6岁[mean±SD],训练=10.9±2.7小时/周,7.1±8.8岁)进行静息代谢率(RMR)、骨密度(BMD)、血液激素生物标志物和最大有氧能力的实验室评估。参与者提供了7天的训练日志和4天的饮食记录。饮食和训练记录用于计算EA。相关性用于检查EA与RMR、BMD、应力性骨折以及生殖、代谢和骨骼生物标志物之间的关联。平均EA为28.7±13.4 kcal/kg无脂肪质量(FFM),这将我们的样本归类为低EA(根据已公布的标准,< 30 kcal/kg FFM)和RED-S高风险。激素和骨生物标志物在正常的临床范围内,即使EA很低。唯一有趣的显著关联是EA与全身骨密度呈负相关(r = -0.360, P =0.005),与预期相反。平均而言,我们的受试者表现出低EA状态,这一标准主要是基于女性研究制定的。尽管如此,我们的参与者没有表现出在被诊断为RED-S的运动员中发现的主要激素或骨骼健康障碍。< 30 kcal/kg FFM值诊断低EA可能不适用于非精英耐力训练的男性。
{"title":"Energy Availability and RED-S Risk Factors in Competitive, Non-elite Male Endurance Athletes.","authors":"Amy R. Lane, A. Hackney, A. Smith‐Ryan, Kristen L. Kucera, J. Register-Mihalik, K. Ondrak","doi":"10.53941/tmep.v1i1.29","DOIUrl":"https://doi.org/10.53941/tmep.v1i1.29","url":null,"abstract":"Relative Energy Deficiency in Sport (RED-S) is predicated on the assumption that low energy availability (EA) induces deficiencies-dysfunction in multiple physiologic systems. However, research on RED-S and EA in male athletes is limited in comparison to women. The aim of this study is to investigate EA and the risk factors for RED-S, and their potential associations in non-elite male endurance athletes. Laboratory assessments for resting metabolic rate (RMR), bone mineral density (BMD), blood hormonal biomarkers and maximal aerobic capacity were conducted on 60 competitive, recreationally trained male endurance athletes (age=43.4±11.6 years [mean±SD], training=10.9±2.7 h/wk, 7.1±8.8 years). Participants provided 7-days of training logs and 4-days of diet records. Diet and training records were used to calculate EA. Correlations were used to examine associations between EA and RMR, BMD, stress fractures and reproductive, metabolic and bone biomarkers. Mean EA was 28.7±13.4 kcal/kg fat free mass (FFM), which categorized our sample as low EA (based upon published criterion, < 30 kcal/kg FFM) and at a high risk for RED-S. Hormonal and bone biomarkers were in normal clinical ranges, even though EA was low. The only interesting significant association was EA being negatively associated with total body BMD (r = -0.360, P =0.005), opposite of expectations. On average our subjects displayed a state of low EA based upon the criterion which has been primarily developed from female-based research. Nonetheless, our participants displayed no major hormonal or bone health disturbances found in athletes diagnosed with RED-S. A value of < 30 kcal/kg FFM to diagnose low EA may not be appropriate for non-elite endurance trained men.","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"1 1","pages":"25-32"},"PeriodicalIF":0.0,"publicationDate":"2021-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88697857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
What Are Good Muscle Endpoints for Translational Studies? 翻译研究的好肌肉终点是什么?
Pub Date : 2021-06-07 DOI: 10.53941/tmep.v1i1.24
J. Rittweger
What Are Good Muscle Endpoints for Translational Studies?Jörn Rittweger()1,21Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany2Department of Pediatrics and Adolescent Medicine, University of Cologne, Cologne, Germany© The Author AbstractMuscles matter to our health because of their size, their involvement in energy metabolism and their relevance for locomotion. Adequate selection of good endpoints is crucial for successfully designing translational studies. At least eight different muscle functions matter to health, namely the mechanical functions of exerting force, velocity, power, elastic storage and braking power, the two metabolic functions of substrate uptake (e.g. carbohydrates, lipids and amino acids) and substrate provision (e.g. lactate and amino acids) and secretory functions. However, specific endpoint tests have been validated for muscle force and power only. Walking speed and grip strength demonstrate good predictive value for hard clinical endpoints, such as disability, loss of autonomy and death. Vertical jump power also has good ecological validity and construct validity, and it depicts excellent test-retest reliability, which is an important advantage with regard to the study of power. Assessment of muscle mass, e.g. by magnetic resonance imaging, dual energy X-ray absorptiometry or bioelectrical impedance, should be considered as an important secondary endpoint to enhance construct validity. Further secondary endpoints should be included wherever they are likely to enhance the plausibility of the study outcome and assessment of test-retest reliability at baseline is always recommended. Well-established methods exist for three relevant muscular endpoints, namely power, strength and muscle mass, and these endpoints lend themselves to utilization in clinical studies. However, such validated methods lack a number of additional muscle functions that are scientifically only emerging. This applies foremost to the metabolic function of muscles but also to its role in storage and dissipation of mechanical energy.
翻译研究的好肌肉终点是什么?Jörn Rittweger()1,21德国科隆航空航天中心航空航天医学研究所2科隆大学儿科和青少年医学系,科隆,德国©作者摘要肌肉对我们的健康至关重要,因为它们的大小,它们参与能量代谢以及它们与运动的相关性。充分选择良好的终点对于成功设计转译研究至关重要。至少有八种不同的肌肉功能与健康有关,即施加力、速度、动力、弹性储存和制动力的机械功能,底物摄取(例如碳水化合物、脂质和氨基酸)和底物供应(例如乳酸和氨基酸)的两种代谢功能以及分泌功能。然而,特定的终点测试仅针对肌肉力量和力量进行了验证。步行速度和握力对硬性临床终点(如残疾、自主性丧失和死亡)具有良好的预测价值。垂直起跳力具有良好的生态效度和结构效度,并具有良好的重测信度,这是动力研究的重要优势。肌肉质量的评估,例如通过磁共振成像、双能x线吸收仪或生物电阻抗,应被视为提高结构效度的重要次要终点。进一步的次要终点应包括在它们可能增强研究结果的可信性的地方,并且总是建议在基线上评估测试-重测的信度。对于三个相关的肌肉终点,即力量、力量和肌肉质量,存在完善的方法,这些终点有助于在临床研究中使用。然而,这种经过验证的方法缺乏一些科学上刚刚出现的额外肌肉功能。这首先适用于肌肉的代谢功能,也适用于它在机械能的储存和耗散中的作用。
{"title":"What Are Good Muscle Endpoints for Translational Studies?","authors":"J. Rittweger","doi":"10.53941/tmep.v1i1.24","DOIUrl":"https://doi.org/10.53941/tmep.v1i1.24","url":null,"abstract":"What Are Good Muscle Endpoints for Translational Studies?\u0000\u0000Jörn Rittweger()1,2\u0000\u0000\u00001Institute of Aerospace Medicine, German Aerospace Center, Cologne, Germany\u00002Department of Pediatrics and Adolescent Medicine, University of Cologne, Cologne, Germany\u0000\u0000© The Author\u0000\u0000 \u0000Abstract\u0000Muscles matter to our health because of their size, their involvement in energy metabolism and their relevance for locomotion. Adequate selection of good endpoints is crucial for successfully designing translational studies. At least eight different muscle functions matter to health, namely the mechanical functions of exerting force, velocity, power, elastic storage and braking power, the two metabolic functions of substrate uptake (e.g. carbohydrates, lipids and amino acids) and substrate provision (e.g. lactate and amino acids) and secretory functions. However, specific endpoint tests have been validated for muscle force and power only. Walking speed and grip strength demonstrate good predictive value for hard clinical endpoints, such as disability, loss of autonomy and death. Vertical jump power also has good ecological validity and construct validity, and it depicts excellent test-retest reliability, which is an important advantage with regard to the study of power. Assessment of muscle mass, e.g. by magnetic resonance imaging, dual energy X-ray absorptiometry or bioelectrical impedance, should be considered as an important secondary endpoint to enhance construct validity. Further secondary endpoints should be included wherever they are likely to enhance the plausibility of the study outcome and assessment of test-retest reliability at baseline is always recommended. Well-established methods exist for three relevant muscular endpoints, namely power, strength and muscle mass, and these endpoints lend themselves to utilization in clinical studies. However, such validated methods lack a number of additional muscle functions that are scientifically only emerging. This applies foremost to the metabolic function of muscles but also to its role in storage and dissipation of mechanical energy.","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90737241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise with Energy Restriction as a Means of Losing Body Mass while Preserving Muscle Quality and Ameliorating Co-morbidities: Towards a Therapy for Obesity? 运动与能量限制作为一种减少体重,同时保持肌肉质量和改善合并症的手段:对肥胖的治疗?
Pub Date : 2021-06-07 DOI: 10.53941/tmep.v1i1.31
Antonia Giacco, E. Silvestri, R. Senese, F. Cioffi, Arianna Cuomo, A. Lombardi, M. Moreno, A. Lanni, P. de Lange
Exercise with Energy Restriction as a Means of Losing Body Mass while Preserving Muscle Quality and Ameliorating Co-morbidities: Towards a Therapy for Obesity?Antonia Giacco1*, Elena Silvestri1*, Rosalba Senese2, Federica Cioffi1, Arianna Cuomo2, Assunta Lombardi3, Maria Moreno1, Antonia Lanni2 and Pieter de Lange()2 1Dipartimento di Science e Tecnologie, Università degli Studi del Sannio, Benevento, Italy2Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università degli Studi della Campania "Luigi Vanvitelli," Caserta, Italy3Dipartimento di Biologia, Università degli Studi di Napoli "Federico II," Napoli, Italy© The Authors AbstractObesity and related co-morbidities are a major public health threat worldwide, and efforts to counteract obesity by means of physiological interventions are currently being explored and applied. Here we present an overview of the literature on the effect of dietary/exercise-based programs on loss of different components of body mass. We also discuss gain or lack of loss of lean mass in view of muscle quality maintenance, which is an important aspect to consider when employing weight-loss strategies to tackle obesity. By comparing results obtained in participants with mild to severe obesity with those obtained in lean participants, we highlight variations in the success of these interventions. Furthermore, we briefly address the observation that although certain interventions may not always affect body composition they can nevertheless ameliorate co-morbidities (insulin resistance, non-alcoholic fatty liver disease). Based on what is currently known, in this narrative review we include data from human and animal studies related to the process of unravelling the mechanisms underlying conservation of functional muscle mass.
运动与能量限制作为一种减少体重,同时保持肌肉质量和改善合并症的手段:对肥胖的治疗?Antonia Giacco1*, Elena Silvestri1*, Rosalba senes2, Federica cioff1, Arianna cuom2, Assunta Lombardi3, Maria Moreno1, Antonia Lanni2和Pieter de Lange()2科学与技术学院,圣安东尼奥大学,贝内文托,意大利2环境科学与技术学院,生物与制药学院,Campania大学,Luigi Vanvitelli, Caserta,意大利3生物学学院,那不勒斯大学,Federico II,摘要肥胖及相关合并症是全球范围内的主要公共卫生威胁,目前正在探索和应用通过生理干预手段对抗肥胖的努力。在这里,我们概述了基于饮食/运动的计划对身体质量不同组成部分损失的影响的文献。我们还从维持肌肉质量的角度讨论了瘦质量的增加或减少,这是采用减肥策略来解决肥胖问题时需要考虑的一个重要方面。通过比较轻度至重度肥胖参与者与瘦弱参与者获得的结果,我们强调了这些干预措施成功的差异。此外,我们简要地指出,尽管某些干预措施可能并不总是影响身体成分,但它们仍然可以改善合并症(胰岛素抵抗、非酒精性脂肪肝)。基于目前已知的情况,在这篇叙述性综述中,我们纳入了与揭示功能性肌肉质量保护机制相关的人类和动物研究数据。
{"title":"Exercise with Energy Restriction as a Means of Losing Body Mass while Preserving Muscle Quality and Ameliorating Co-morbidities: Towards a Therapy for Obesity?","authors":"Antonia Giacco, E. Silvestri, R. Senese, F. Cioffi, Arianna Cuomo, A. Lombardi, M. Moreno, A. Lanni, P. de Lange","doi":"10.53941/tmep.v1i1.31","DOIUrl":"https://doi.org/10.53941/tmep.v1i1.31","url":null,"abstract":"Exercise with Energy Restriction as a Means of Losing Body Mass while Preserving Muscle Quality and Ameliorating Co-morbidities: Towards a Therapy for Obesity?\u0000\u0000Antonia Giacco1*, Elena Silvestri1*, Rosalba Senese2, Federica Cioffi1, Arianna Cuomo2, Assunta Lombardi3, Maria Moreno1, Antonia Lanni2 and Pieter de Lange()2 \u0000\u0000\u00001Dipartimento di Science e Tecnologie, Università degli Studi del Sannio, Benevento, Italy\u00002Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università degli Studi della Campania \"Luigi Vanvitelli,\" Caserta, Italy\u00003Dipartimento di Biologia, Università degli Studi di Napoli \"Federico II,\" Napoli, Italy\u0000\u0000© The Authors\u0000\u0000 \u0000Abstract\u0000Obesity and related co-morbidities are a major public health threat worldwide, and efforts to counteract obesity by means of physiological interventions are currently being explored and applied. Here we present an overview of the literature on the effect of dietary/exercise-based programs on loss of different components of body mass. We also discuss gain or lack of loss of lean mass in view of muscle quality maintenance, which is an important aspect to consider when employing weight-loss strategies to tackle obesity. By comparing results obtained in participants with mild to severe obesity with those obtained in lean participants, we highlight variations in the success of these interventions. Furthermore, we briefly address the observation that although certain interventions may not always affect body composition they can nevertheless ameliorate co-morbidities (insulin resistance, non-alcoholic fatty liver disease). Based on what is currently known, in this narrative review we include data from human and animal studies related to the process of unravelling the mechanisms underlying conservation of functional muscle mass.","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84085109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Energy Availability and RED-S Risk Factors in Competitive, Non-elite Male Endurance Athletes. 竞技非精英男性耐力运动员能量可得性与RED-S危险因素
Pub Date : 2021-01-01 Epub Date: 2021-06-07
Amy R Lane, Anthony C Hackney, Abbie E Smith-Ryan, Kristen Kucera, Johna K Register-Mihalik, Kristin Ondrak

Relative Energy Deficiency in Sport (RED-S) is predicated on the assumption that low energy availability (EA) induces deficiencies-dysfunction in multiple physiologic systems. However, research on RED-S and EA in male athletes is limited in comparison to women. The aim of this study is to investigate EA and the risk factors for RED-S, and their potential associations in non-elite male endurance athletes. Laboratory assessments for resting metabolic rate (RMR), bone mineral density (BMD), blood hormonal biomarkers and maximal aerobic capacity were conducted on 60 competitive, recreationally trained male endurance athletes (age=43.4±11.6 years [mean±SD], training=10.9±2.7 h/wk, 7.1±8.8 years). Participants provided 7-days of training logs and 4-days of diet records. Diet and training records were used to calculate EA. Correlations were used to examine associations between EA and RMR, BMD, stress fractures and reproductive, metabolic and bone biomarkers. Mean EA was 28.7±13.4 kcal/kg fat free mass (FFM), which categorized our sample as low EA (based upon published criterion, < 30 kcal/kg FFM) and at a high risk for RED-S. Hormonal and bone biomarkers were in normal clinical ranges, even though EA was low. The only interesting significant association was EA being negatively associated with total body BMD (r = -0.360, P =0.005), opposite of expectations. On average our subjects displayed a state of low EA based upon the criterion which has been primarily developed from female-based research. Nonetheless, our participants displayed no major hormonal or bone health disturbances found in athletes diagnosed with RED-S. A value of < 30 kcal/kg FFM to diagnose low EA may not be appropriate for non-elite endurance trained men.

运动中的相对能量不足(RED-S)是基于低能量可用性(EA)导致多个生理系统的缺陷和功能障碍的假设。然而,与女性相比,男性运动员的RED-S和EA研究有限。本研究旨在探讨非优秀男性耐力运动员EA、RED-S危险因素及其潜在关联。对60名竞技性、娱乐性训练的男性耐力运动员(年龄=43.4±11.6岁[mean±SD],训练=10.9±2.7小时/周,7.1±8.8岁)进行静息代谢率(RMR)、骨密度(BMD)、血液激素生物标志物和最大有氧能力的实验室评估。参与者提供了7天的训练日志和4天的饮食记录。饮食和训练记录用于计算EA。相关性用于检查EA与RMR、BMD、应力性骨折以及生殖、代谢和骨骼生物标志物之间的关联。平均EA为28.7±13.4 kcal/kg无脂肪质量(FFM),这将我们的样本归类为低EA(根据已公布的标准,< 30 kcal/kg FFM)和RED-S高风险。激素和骨生物标志物在正常的临床范围内,即使EA很低。唯一有趣的显著关联是EA与全身骨密度呈负相关(r = -0.360, P =0.005),与预期相反。平均而言,我们的受试者表现出低EA状态,这一标准主要是基于女性研究制定的。尽管如此,我们的参与者没有表现出在被诊断为RED-S的运动员中发现的主要激素或骨骼健康障碍。< 30 kcal/kg FFM值诊断低EA可能不适用于非精英耐力训练的男性。
{"title":"Energy Availability and RED-S Risk Factors in Competitive, Non-elite Male Endurance Athletes.","authors":"Amy R Lane,&nbsp;Anthony C Hackney,&nbsp;Abbie E Smith-Ryan,&nbsp;Kristen Kucera,&nbsp;Johna K Register-Mihalik,&nbsp;Kristin Ondrak","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Relative Energy Deficiency in Sport (RED-S) is predicated on the assumption that low energy availability (EA) induces deficiencies-dysfunction in multiple physiologic systems. However, research on RED-S and EA in male athletes is limited in comparison to women. The aim of this study is to investigate EA and the risk factors for RED-S, and their potential associations in non-elite male endurance athletes. Laboratory assessments for resting metabolic rate (RMR), bone mineral density (BMD), blood hormonal biomarkers and maximal aerobic capacity were conducted on 60 competitive, recreationally trained male endurance athletes (age=43.4±11.6 years [mean±SD], training=10.9±2.7 h/wk, 7.1±8.8 years). Participants provided 7-days of training logs and 4-days of diet records. Diet and training records were used to calculate EA. Correlations were used to examine associations between EA and RMR, BMD, stress fractures and reproductive, metabolic and bone biomarkers. Mean EA was 28.7±13.4 kcal/kg fat free mass (FFM), which categorized our sample as low EA (based upon published criterion, < 30 kcal/kg FFM) and at a high risk for RED-S. Hormonal and bone biomarkers were in normal clinical ranges, even though EA was low. The only interesting significant association was EA being negatively associated with total body BMD (<i>r</i> = -0.360, <i>P</i> =0.005), opposite of expectations. On average our subjects displayed a state of low EA based upon the criterion which has been primarily developed from female-based research. Nonetheless, our participants displayed no major hormonal or bone health disturbances found in athletes diagnosed with RED-S. A value of < 30 kcal/kg FFM to diagnose low EA may not be appropriate for non-elite endurance trained men.</p>","PeriodicalId":93388,"journal":{"name":"Translational medicine and exercise prescription","volume":"1 1","pages":"25-32"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294781/pdf/nihms-1710710.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39215547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Translational medicine and exercise prescription
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1